2,3-dihydro-1,4-dioxin-5-yl-[(3R)-3-[methyl-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]amino]pyrrolidin-1-yl]methanone
C16H24N4O4 — CID 124888820
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,3-dihydro-1,4-dioxin-5-yl-[(3R)-3-[methyl-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]amino]pyrrolidin-1-yl]methanone
2,3-dihydro-1,4-dioxin-5-yl-[(3R)-3-[methyl-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]amino]pyrrolidin-1-yl]methanone (PubChem CID 124888820) has the molecular formula C16H24N4O4 and a molecular weight of 336.39 g/mol. Its IUPAC name is 2,3-dihydro-1,4-dioxin-5-yl-[(3R)-3-[methyl-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]amino]pyrrolidin-1-yl]methanone.
Molecular Properties
| Compound Name | 2,3-dihydro-1,4-dioxin-5-yl-[(3R)-3-[methyl-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]amino]pyrrolidin-1-yl]methanone |
|---|---|
| PubChem CID | 124888820 |
| Molecular Formula | C16H24N4O4 |
| Molecular Weight | 336.39 g/mol |
| Exact Mass | 336.18 |
| IUPAC Name | 2,3-dihydro-1,4-dioxin-5-yl-[(3R)-3-[methyl-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]amino]pyrrolidin-1-yl]methanone |
| SMILES | CC(C)c1nc(CN(C)[C@@H]2CCN(C(=O)C3=COCCO3)C2)no1 |
| InChI | InChI=1S/C16H24N4O4/c1-11(2)15-17-14(18-24-15)9-19(3)12-4-5-20(8-12)16(21)13-10-22-6-7-23-13/h10-12H,4-9H2,1-3H3/t12-/m1/s1 |
| InChIKey | NEXYYIXBQOXJBX-GFCCVEGCSA-N |
| XLogP | 1.11 |
| TPSA | 80.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 336.39 |
| LogP ≤ 5 | 1.11 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124888820 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.